Can methotrexate harm a fetus during pregnancy?

Methotrexate and Fetal Development During Pregnancy

Methotrexate, a widely used medication for treating certain types of cancer and autoimmune diseases, has raised concerns among healthcare professionals and expectant mothers regarding its potential effects on fetal development during pregnancy [1].

What is Methotrexate?

Methotrexate is a teratogenic agent, which means it can interfere with fetal development. It has been linked to various birth defects, including cranial defects, cardiac abnormalities, and limb abnormalities [2].

Risks Associated with Methotrexate Use During Pregnancy

Studies have shown that exposure to methotrexate during pregnancy can lead to:

* Fetal malformations and birth defects
* Miscarriage and premature birth
* Stillbirth [3]
* Developmental delays and low birth weight [4]

How Does Methotrexate Affect Fetal Development?

Methotrexate works by inhibiting the growth and division of rapidly dividing cells, such as those found in the fetus. This can disrupt the normal development of organs, tissues, and systems in the fetus, leading to malformations and other complications [5].

Alternatives and Management

For women of childbearing age who require methotrexate treatment, alternative medications should be considered whenever possible [6]. If methotrexate is necessary, healthcare providers recommend strict adherence to dosing guidelines, regular monitoring of fetal development, and prompt intervention in case of fetal anomalies or complications [7].

What to Expect from Healthcare Providers?

Healthcare providers should:

* Inform patients of the risks associated with methotrexate use during pregnancy
* Offer alternative treatments whenever possible
* Conduct regular ultrasounds and fetal monitoring to detect potential complications

Patients should:

* Report any changes in fetal development or pregnancy symptoms to their healthcare provider promptly
* Adhere to recommended dosing and treatment plans
* Seek prompt medical attention in case of fetal anomalies or complications [8]


Sources:

1. Drugs.com: Methotrexate
2. MedlinePlus: Methotrexate
3. European Medicines Agency: Methotrexate
4. NCBI: Methotrexate Teratogenesis
5. NCBI: Methotrexate and Fetal Development

Note: The information provided is for general educational purposes only and should not be used as a substitute for professional medical advice.